Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.

Annals of hematology - 1 Feb 1992

Reuss-Borst M A, Steinke B, Waller H D, Bühring H J, Müller C A

Abstract excerpt

The precise phenotype and clinical course are described of a subgroup of acute nonlymphoblastic leukemias (ANLL) expressing the NK-cell differentiation antigen CD56. As previously reported, CD56+ leukemias occurred in a frequency of about 20% of ANLL cases showing clinical and immunophenotypical heterogeneity. Carrying various myelomonocytic markers, all cases were diagnosed to be of nonlymphoid origin. Positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antigens, CD
Share to Antigens, Differentiation, T-Lymphocyte

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bone Marrow

Share to CD56 Antigen

Share to Immunophenotyping

Share to Leukemia, Myeloid, Acute

Share to Phenotype

Source

Identifiers

PMID: 1372833
DOI: 10.1007/BF01715349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.PMID 1372833Read ↗

Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.Semantic proximity Read ↗

NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia.Semantic proximity Read ↗

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia.Semantic proximity Read ↗

Variable manifestation in natural killer cell leukaemia.Semantic proximity Read ↗

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.Semantic proximity Read ↗

Natural killer cell neoplasmsSemantic proximity Read ↗

Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.Semantic proximity Read ↗

CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy.Semantic proximity Read ↗

Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosisSemantic proximity Read ↗

Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia.Semantic proximity Read ↗

Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.